- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03564769
Evaluation Study of SPOTme® Skin Cancer Screenings
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Despite tremendous growth in both the interest and volume of skin cancer screenings at the national level, the actual utility and impact of the AAD SPOT me™ skin cancer screening programs have not been fully evaluated. This study will address this knowledge gap. Early detection is vital in the fight against skin cancer, the most common cancer in the United States. While the effects of skin cancer can be devastating, this disease is highly treatable when detected early.
This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02115
- Harvard TH Chan School of Public Health
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Participated in the American Academy of Dermatology national screening program in 2016 or 2017
- Have a presumptive diagnosis (screening, non-confirmed) of melanoma
- Have provided the AAD with permission to be re-contacted
- Have provided the AAD with an email address
- Aged 18 years or older
- Able to read English
Exclusion Criteria:
- None
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Intervention Arm 1
Individuals randomized to intervention group 1 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 AND will receive additional skin cancer screening educational materials.
|
Individuals randomized to the intervention group will receive skin cancer screening educational materials.
All study participants will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017.
|
Eksperimentel: Intervention Arm 2
Individuals randomized to intervention group 2 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 only.
|
All study participants will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Completion of a physician skin examination
Tidsramme: Baseline
|
Self-report of a physician skin examination will be defined as a health care provider examining the patient's entire body for any sign of skin cancer during the period following patient's receipt of an AAD SPOTme® skin cancer screening to the baseline assessment.
|
Baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Completion of a physician skin examination
Tidsramme: 6 months
|
Self-report of a physician skin examination will be defined as a health care provider examining the patient's entire body for any sign of skin cancer during the 3 months prior to the 6-month follow up assessment
|
6 months
|
Patient thorough skin self-examination (TSSE)
Tidsramme: 6 months
|
Self-report of patient thorough skin self-examination (TSSE) will be defined as performing at least one TSSE during the 3 months prior to the 6-month follow up assessment
|
6 months
|
Patient attitude towards sun protection
Tidsramme: 6 months
|
Self-report of patient attitude towards use of sun protection will be defined by likelihood of engaging in sun protection practices in the year following the 6-month follow up assessment
|
6 months
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Alan Geller, MPH, RN, Harvard TH Chan School of Public Health
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 17-1668
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Hudkræft
-
Alma LasersTrukket tilbageSkin ResurfacingForenede Stater
-
R2 DermatologyAfsluttet
-
Syneron MedicalAfsluttetSkin Resurfacing | RynkereduktionForenede Stater, Canada
-
University of Split, School of MedicineAfsluttetSkin Recovery i forskellige humane hudskademodellerKroatien
-
Centre Hospitalier le MansRekruttering
-
The First Affiliated Hospital of Dalian Medical...UkendtSår og skader | Trauma | Brud, åben | Skin ExpanderKina
-
Integrative Skin Science and ResearchBurt's Bees Inc.RekrutteringAcne | Skin MicroboimeForenede Stater
-
PT. Daewoong InfionEquilab InternationalAfsluttetHudtransplantatar | Split-Thickness Skin Graft (STSG)Indonesien
-
Chang Gung Memorial HospitalIkke rekrutterer endnuAtletiske skader | Eksematiske hudsygdomme | Skin Avulsion
-
ScotiadermIkke rekrutterer endnuIntertrigo | Inkontinens-associeret dermatitis | Moisture Associated Skin Damage (MASD) (f.eks. inkontinens-associeret dermatitis [IAD], sved, dræning)
Kliniske forsøg med Intervention Arm
-
Jonsson Comprehensive Cancer CenterAmerican Cancer Society, Inc.AfsluttetKolorektal cancerForenede Stater
-
Massachusetts General HospitalAfsluttetAkut koronarsyndromForenede Stater
-
Centro Hospitalar e Universitário de Coimbra, E...Ikke rekrutterer endnu
-
UConn HealthNational Heart, Lung, and Blood Institute (NHLBI)Afsluttet
-
St. Louis UniversityEpharmix, Inc.AfsluttetKort tarm syndromForenede Stater
-
Washington University School of MedicineAfsluttetDepressive symptomer | SorgForenede Stater
-
Massachusetts General HospitalNational Institutes of Health (NIH); National Institute on Aging (NIA)RekrutteringDemens | Alzheimers demens | Caregiver Stress Syndrome | Plejerudbrændthed | Demens, mild | Demens Moderat | Svær demens | Demens FrontotemporalForenede Stater
-
Lawson Health Research InstituteAfsluttetKronisk nyresygdomCanada
-
University of California, RiversideRekruttering
-
University of MinnesotaNational Institute on Deafness and Other Communication Disorders (NIDCD)RekrutteringDysfoni | Stemmeforstyrrelser | Funktionel dysfoniForenede Stater